在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Mouse B- and T-lymphocyte attenuator(BTLA) ELISA kit

  • 中文名稱:
    小鼠B和T淋巴細胞衰減因子(BTLA)酶聯免疫試劑盒
  • 貨號:
    CSB-EL002868MO
  • 規格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產品詳情

  • 產品描述:
    小鼠B和T淋巴細胞衰減因子(BTLA)酶聯免疫試劑盒(CSB-EL002868MO)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的BTLA含量。BTLA即B和T淋巴細胞衰減蛋白,是一種負性共刺激分子。其背景在于它在免疫調節里至關重要。研究機制上,BTLA與配體結合后,能傳遞抑制性信號,抑制T細胞和B細胞的活化、增殖等功能,在維持免疫穩態、腫瘤免疫等方面有深入研究。試劑盒檢測范圍為0.625 ng/mL-40 ng/mL,該產品可廣泛應用于免疫調節機制研究、自身免疫性疾病模型分析、腫瘤免疫微環境探索以及免疫治療藥物開發等科研領域,為深入解析BTLA在細胞信號通路中的作用提供可靠工具。本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    Btla ELISA Kit; B- and T-lymphocyte attenuator ELISA Kit; B- and T-lymphocyte-associated protein ELISA Kit; CD antigen CD272 ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Mus musculus (Mouse)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    0.625 ng/mL-40 ng/mL
  • 靈敏度:
    0.156 ng/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Immunology
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

靶點詳情

  • 功能:
    Inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2. May interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14. In cis interactions, appears to play an immune regulatory role inhibiting in trans interactions in naive T cells to maintain a resting state. In trans interactions, can predominate during adaptive immune response to provide survival signals to effector T cells.
  • 基因功能參考文獻:
    1. these data support a role of BTLA on type I NKT cells in limiting anti-tumor immunity. PMID: 29518903
    2. these data indicate that HVEM/BTLA interactions are dispensable for the formation of de novo host antidonor isotype-specific antibodies following skin transplantation PMID: 26924526
    3. The percentage of circulating BTLA+CD4+ lymphocytes was significantly higher in mice with LPS-induced acute lung inflammation. PMID: 28164546
    4. Dendritic cells require BTLA and HVEM to actively adjust tolerizing T cell responses under steady-state conditions. PMID: 27793593
    5. these data indicate that CCR7 and BTLA cooverexpression imparts an intermediate immune phenotype in mmature dendritic cells when compared to that in CCR7- or BTLA-expressing counterparts that show a more immunocompetent or immunotolerant phenotype PMID: 28393074
    6. this study shows that miR-155 is involved in the inhibition of BTLA during CD4+ T cell activation PMID: 27350630
    7. Our findings indicate that BTLA may be involved in the control of inflammatory responses through increasing Foxp3 expression, rather than attenuating IL-17 production, in dextran sulfate sodium-induced colitis. PMID: 25973010
    8. This study uncovers a BTLA-mediated strategy used by the host that permits Listeria proliferation to enable increasing T cell responses for long-term protection. PMID: 25011109
    9. results support a model whereby BTLA on innate leukocytes is triggered by HVEM and delivers negative signals into BTLA(+) cells, thereby interfering with the protective immune response to this intestinal parasite. PMID: 25595777
    10. by coordinating expression of BTLA, RORgammat and IL-7 balance suppressive and activation stimuli to regulate gammadelta T cell homeostasis and inflammatory responses PMID: 24315996
    11. BTLA promotes the pathogenesis of virus-induced fulminant hepatitis by enhancing macrophage viability and function. Targeting BTLA may be a novel strategy for the treatment of FH. PMID: 22637698
    12. B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells. PMID: 23479601
    13. These findings support role for BTLA and/or HVEM as potential, novel diagnostic markers of innate immune response/status and as therapeutic targets of sepsis. PMID: 22459947
    14. Combined blockade of BTLA and herpesvirus entry mediator (HVEM) does not inhibit donor T cell infiltration into graft-versus-host reaction organs; instead, it decreases the functional activity of the alloreactive T cells. PMID: 22490863
    15. During increased resistance to malaria infection, BTLA regulates production of proinflammatory cytokines in a T cell-intrinsic way, while B cells intrinsically regulate the production of nonlethal Plasmodium yoelii 17NL-specific antibodies. PMID: 21998455
    16. BTLA receptor is a potential immunoregulatory target for the modulation of cytotoxic T-lymphocyte-mediated PMID: 21978997
    17. dichotomous functions of BTLA in GVHD to serve as a costimulatory ligand of HVEM and to transmit inhibitory signal as a receptor PMID: 21220749
    18. The effect of the B and T lymphocyte attenuator (BTLA; CD272) on cluster of differentiation (CD)4(+) T cell-mediated corneal immunopathology during murine herpetic stromal keratitis, was investigated. PMID: 21042564
    19. Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression. PMID: 21078889
    20. BTLA suppresses IgG2a and IgG2b production in vivo by inhibiting interleukin (IL)-21 production from follicular T helper (Th) cells. PMID: 20660710
    21. The subcellular localization of BTLA in mouse T cells in a steady state, as well as upon activation, was examined. PMID: 19892849
    22. The extracellular domain of BTLA binds herpesvirus entry mediator (HVEM), blocks BTLA-HVEM interactions and significantly improves antitumor immunity in cervical cancer when combined with heat shock protein (HSP)70 vaccine. PMID: 19923459
    23. BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1). PMID: 12796776
    24. BTLA is expressed by all mature lymphocytes, splenic macrophages, and mature, but not immature bone marrow-derived dendritic cells. BTLA is implicated as a negative regulator of the activation and/or function of various hemopoietic cell types. PMID: 15128774
    25. Binding of HVEM to BTLA attenuates T cell activation, identifying HVEM/BTLA as a coinhibitory receptor pair. PMID: 15647361
    26. existence of three distinct BTLA alleles among 23 murine strains, differing both in Ig domain structure and cellular distribution of expression on lymphoid subsets PMID: 15749870
    27. BTLA adds to the growing list of cell surface proteins that are potential targets to down-modulate T cell function. PMID: 16272294
    28. these receptors are critical determinants of the duration of allergic airway inflammation PMID: 16547224
    29. BTLA had a regulatory effect on the expression of B7 on dendritic cells. PMID: 16805995
    30. mice deficient in full-length BTLA or its ligand, herpesvirus entry mediator, had increased number of memory CD8(+) T cells PMID: 17206146
    31. BTLA inhibits antigen-induced eosinophil recruitment into the airways by preventing IL-5 production from Th2 cells. PMID: 17541277
    32. These results suggest that BTLA functions to regulate T-cell signaling by controlling the phosphorylated form of TCRzeta accumulation in the lipid raft. PMID: 17607320
    33. BTLA-herpesvirus entry mediator (HVEM) interactions are functionally involved in T cell regulation during Plasmodium berghei strain ANKA blood-stage malaria and regulate sequestration of T cells in brain capillaries. PMID: 17785848
    34. The LTbetaR and HVEM-BTLA pathways form an integrated signaling network regulating DC homeostasis. PMID: 18097025
    35. BTLA employs a conserved binding mode for herpesvirus entry mediator recognition. PMID: 18178834
    36. HVEM triggers inhibitory signals by acting as a ligand that binds to B and T lymphocyte attenuator (BTLA), an immunoglobulin super family member. PMID: 18519647
    37. BTLA plays an important role in the maintenance of immune tolerance and the prevention of autoimmune diseases. PMID: 18668554
    38. role of BTLA on the proliferation, recruitment, and survival of T cells in response to inhaled allergen PMID: 18713967
    39. demonstrate an important role for BTLA in the induction of peripheral tolerance of both CD4(+) and CD8(+) T cells in vivo PMID: 19342624
    40. B and T lymphocyte attenuator (BTLA) coinhibitory signaling of natural killer T (NKT) cells is required to temper early inflammation in a model of acute hepatitis. PMID: 19535622
    41. role in down-modulating immune responses[REVIEW] PMID: 19567411
    42. engagement of the newly discovered coinhibitory receptor B and T lymphocyte attenuator (BTLA) by herpesvirus entry mediator (HVEM) is critical for negatively regulating early host immunity against intracellular bacteria. PMID: 19587015
    43. the HVEM-BTLA cis-complex competitively inhibits HVEM activation by ligands expressed in the surrounding microenvironment, thus helping maintain T cells in the naive state. PMID: 19915044
    44. BTLA functions as the inhibitory coreceptor of NKT cells PMID: 19949073

    顯示更多

    收起更多

  • 亞細胞定位:
    Cell membrane; Single-pass type I membrane protein.
  • 組織特異性:
    Expressed in splenic T- and B-cells as well as lymph node tissues but very weakly in somatic tissues. Also expressed in macrophages, NK cells and dendritic cells. A polymorphic tissue distribution between several strains is seen.
  • 數據庫鏈接:


主站蜘蛛池模板: 国产日韩欧美亚欧在线| 亚洲妇女无套内射精| 日韩精品久久久久久免费| 日韩 欧美 国产 一区三| 亚洲18禁私人影院| 亚洲精品久久久一区| 欧美人成视频在线视频| 一本一本久久aa综合精品| 51福利国产在线观看午夜天堂| www亚洲精品久久久乳| 无码日韩精品一区二区免费| 97夜夜澡人人爽人人模人人喊| 伊人久久丁香色婷婷啪啪| 一本一道精品欧美中文字幕| √天堂8资源中文在线| 中文字幕人妻偷伦在线视频| 亚洲 自拍 色综合图区av | 亚洲人成77777在线播放网站不卡 国产 | 欧洲野花视频天堂视频p 亚洲aⅴ天堂av天堂无码 | 久久超乳爆乳中文字幕| 久久久久国色av免费观看性色| 大又大粗又爽又黄少妇毛片免费 | 久久婷婷国产综合精品| 国产美女久久久亚洲综合| 免费人成黄页在线观看国产| 亚洲国产成人精品福利| 日韩av无码中文字幕| 欧美 日韩 国产 成人 在线观看| 丰满少妇高潮惨叫久久久| 在线天堂资源www在线中文| 欧美 日韩 亚洲 在线| 18禁男女爽爽爽午夜网站免费| 亚洲国产精品一区二区成人片| 野外做受又硬又粗又大视幕| 亚洲精品久久av无码一区二区| 亚洲毛片无码不卡av在线播放| 亚洲无线码在线一区观看| 天天做天天爱夜夜爽毛片毛片| 国产制服日韩丝袜86页| 西西人体大胆无码视频| 亚洲成a∨人片在无码2023| 欧美激情乱人伦|